Ashleigh is currently an acting team leader in the FDA Division of Medication Error Prevention and Analysis (DMEPA) in CDER’s Office of Surveillance and Epidemiology where she is responsible for increasing the safe use of CDER-regulated drug products by minimizing use error related to their naming, labeling, packaging, or design. She has also worked on postmarket and policy projects on DMEPA’s Rapid Response Team. She is a graduate of the University of Maryland School of Pharmacy and completed her PGY-1 Pharmacy Practice and PGY-2 Critical Care residencies at the University of Maryland Medical Center (UMMC) and the R Adams Cowley Shock Trauma Center. Prior to joining FDA, she worked as a clinical pharmacy specialist and clinical assistant professor in the Cardiac Surgery ICU at UMMC.